American Journal of Tropical Medicine and Hygiene · 2011 · 34 citations · 16 references
Veterinary MedicineInfectious DiseasesPharmacotherapyHelminthologyParasitic Skin DiseaseParasitologyAnthelmintic PharmacologyAntiparasitic ChemotherapyAntiparasitic PharmacotherapyAntiparasitic TherapyHelminth InfectionsIntestinal ParasitologyAnthelmintic Drug TherapyAntihelminthic TherapyAntileishmanial TreatmentAntiparasitic Treatment ResponseControl Group DesignParasitic Infection TreatmentPlacebo-controlled Efficacy AssessmentTreatment Of Leishmaniasis
Helminth infections influence the clinical response to certain diseases and are associated with delayed healing time of patients with cutaneous leishmaniasis (CL) caused by Leishmania braziliensis. We conducted a randomized, double-blind, placebo-controlled clinical trial to examine the role of early versus deferred treatment of intestinal helminth infection on the clinical course of patients with CL treated with pentavalent antimony. (Clinicaltrials.gov number NCT00469495). A total of 90 patients were enrolled, 51.1% (N = 23) of control patients had persistent lesions at Day 90, compared with 62.2% (N = 28) in the treatment group (difference 11.1%, 95% confidence interval = -9.1-30.0%). There was no statistically significant difference in overall time to cure between groups, although there was a tendency for shorter cure times in the control group. This study shows that early introduction of antihelminthic therapy does not improve clinical outcome in patients co-infected with helminths and L. braziliensis.
16
Up-Regulation of Th1-Type Responses in Mucosal Leishmaniasis Patients
Olı́via Bacellar, Hélio A. Lessa, Albert Schriefer et al. · Infection and Immunity · 2002 · 381 citations · Full text
Gustavo Adolfo Sierra Romero, M V Guerra, Marcilene Gomes Paes et al. · American Journal of Tropical Medicine and Hygiene · 2001 · 213 citations